# Cardiometabolic Consequences of the Loss of Ovarian Function

> **NCT06264882** · PHASE4 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 100 (estimated)

## Conditions studied

- Menopause
- Estrogen Deficiency
- Aging
- Adiposity

## Interventions

- **DRUG:** Degarelix
- **DRUG:** Transdermal Estradiol Patch
- **DRUG:** Transdermal Placebo Patch

## Key facts

- **NCT ID:** NCT06264882
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06264882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06264882, "Cardiometabolic Consequences of the Loss of Ovarian Function". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06264882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*